Report Company Directory

FOTEX HLDG SE CO LTD

Foundation Building Materials

• Foundation Building Materials, Inc.: Discontinuing Coverage by Barclays
• The Barclays Real Estate A.G.E.N.T.: Competition Pushes Home Prices Higher Through Seasonally Softer Period by Barclays
• U.S. Homebuilding & Building Products: The 4Q'20 Earnings Setup by Barclays
• US Homebuilding & Building Products: Price-Cost Tracker by Barclays
• U.S. Building Products: Imports Gaining Share by Barclays
• US Homebuilding & Building Products: 2021 Outlook Investor Feedback by Barclays
• GMS | Notes From The Road; Marketing in NY With GMS CEO Turner by Raymond James
• Raymond James Morning Notes - ABCB, AJG, ALTA, AMGN, AX, CMBM, CSTR, EHTH, FBIZ, FMNB, FRME, FSBW, HBNC, HBT, HTBK, LEVL, MBIN, QCRH, SBCF, TSC, UBSI, UVSP by Raymond James
• FBM | Dropping Coverage Due to Acquisition by American Securities by Raymond James
• The Week to Come: Building Products, Construction Materials, & Specialty Distribution by Raymond James

FOUNDATION HEALTHCARE INC

Foundation Medicine Inc.

• 1 director sold by SmartInsider
• Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights by BusinessWire
• Foundation Medicine Launches Gene Expression Profiling Program to Identify Known and Novel Biomarkers in Advanced Cancer by BusinessWire
• Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China by BusinessWire
• Foundation Medicine’s New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration by BusinessWire
• Foundation Medicine Announces Timing for First Quarter 2018 Financial Results and Conference Call by BusinessWire
• Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies by BusinessWire
• Foundation Medicine Announces Commercial Availability of FoundationOne CDxâ„¢, the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Companion Diagnostics by BusinessWire
• Foundation Medicine Announces Final National Coverage Determination (NCD) from the Centers for Medicare & Medicaid Services (CMS), Including Coverage for FoundationOne CDxâ„¢ Across All Solid Tumors by BusinessWire
• Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval for FoundationOne CDxâ„¢ in Japan by BusinessWire

FOUNDER GROUP LTD

• Founder Group Limited Announces 100 for 1 Share Combination by GlobeNewsWire
• Founder Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency by GlobeNewsWire
• Founder Group Limited Announces Landmark RM1.16 billion [USD276 million] 310 MWp Solar-Plus-Storage Project in Sarawak, Anchoring Regional Green Data Centre by GlobeNewsWire
• Founder Group Limited to Significantly Benefit From up to RM17.4 billion [USD4.1 billion] Solar EPCC Contract Value Expected to Ignite Green Energy, Data Center Expansion and National AI Ambitions in Malaysia by GlobeNewsWire
• Founder Group Limited Secures US$2.36 million Contract for a 30MW Large Scale Solar Plant in Malaysia by GlobeNewsWire
• Founder Group Management Comments on Market Conditions in the U.S. for Solar Power Companies’ Stocks by GlobeNewsWire
• Founder Group Signs Memorandum of Understanding with GCL Systems Integration Technology Co., Ltd. to Cooperate on Renewable Energy Projects Valued at up to USD $220 Million by GlobeNewsWire
• Founder Group Secures Additional Contracts with Solar Installation Companies in Malaysia of US$ 1.5 Million by GlobeNewsWire
• Founder Group Secures Contract Valued at US$2.6 Million to Build a Roof-Top Solar Generating Facility in Malaysia by GlobeNewsWire
• Founder Group Secures Letter of Award Valued at US$4.5 Million for Floating Solar Farm Project in Malaysia by GlobeNewsWire